RANKL, a necessary chance for clinical application to osteoporosis and cancer-related bone diseases
Author:
Publisher
Baishideng Publishing Group Inc.
Subject
Orthopedics and Sports Medicine
Reference72 articles.
1. Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone Density
2. Isolation of a Novel Cytokine from Human Fibroblasts That Specifically Inhibits Osteoclastogenesis
3. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
4. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998;93:165-176.
Cited by 45 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Rapid correction of chronic hyperglycemia and bone remodeling, warning against overdoing;World Journal of Diabetes;2024-09-15
2. Artemether Inhibits RANKL-Induced Osteoclast Differentiation and Prevents Bone Loss in Ovariectomized Mice;Revista Brasileira de Farmacognosia;2023-06-12
3. DCIR suppresses osteoclastic proliferation and resorption by downregulating M-CSF and RANKL signaling;Frontiers in Immunology;2023-05-17
4. Discovery of RANKL and the current and future impact of its research;Folia Pharmacologica Japonica;2023-05-01
5. Calcium phosphate-adsorbable and acid-degradable carboxylated polyrotaxane consisting of β-cyclodextrins suppresses osteoclast resorptive activity;Dental Materials Journal;2022-07-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3